BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11576217)

  • 21. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-responsiveness of antigen-experienced CD4 T cells reflects more stringent co-stimulatory requirements.
    Hamel ME; Noteboom E; Kruisbeek AM
    Immunology; 1998 Mar; 93(3):366-75. PubMed ID: 9640247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse B cell activation is inhibited by CD44 cross-linking.
    Wyant TL; Fisher MT; McKallip RJ; Nagarkatti PS; Nagarkatti M; Conrad DH
    Immunol Invest; 2005; 34(4):399-416. PubMed ID: 16304729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
    Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals.
    Njongmeta LM; Bray J; Davies CJ; Davis WC; Howard CJ; Hope JC; Palmer GH; Brown WC; Mwangi W
    Vaccine; 2012 Feb; 30(9):1624-35. PubMed ID: 22240344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.
    Portoles P; Rojo J; Golby A; Bonneville M; Gromkowski S; Greenbaum L; Janeway CA; Murphy DB; Bottomly K
    J Immunol; 1989 Jun; 142(12):4169-75. PubMed ID: 2470817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
    Johnson-Léger C; Christensen J; Klaus GG
    Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
    J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An essential role for gp39, the ligand for CD40, in thymic selection.
    Foy TM; Page DM; Waldschmidt TJ; Schoneveld A; Laman JD; Masters SR; Tygrett L; Ledbetter JA; Aruffo A; Claassen E; Xu JC; Flavell RA; Oehen S; Hedrick SM; Noelle RJ
    J Exp Med; 1995 Nov; 182(5):1377-88. PubMed ID: 7595208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
    Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
    Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization.
    Williams EL; Tutt AL; Beers SA; French RR; Chan CH; Cox KL; Roghanian A; Penfold CA; Butts CL; Boross P; Verbeek JS; Cragg MS; Glennie MJ
    J Immunol; 2013 Oct; 191(8):4130-40. PubMed ID: 24026082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells.
    Croft M; Joseph SB; Miner KT
    J Immunol; 1997 Oct; 159(7):3257-65. PubMed ID: 9317124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of murine CD70 by molecular cloning and mAb.
    Oshima H; Nakano H; Nohara C; Kobata T; Nakajima A; Jenkins NA; Gilbert DJ; Copeland NG; Muto T; Yagita H; Okumura K
    Int Immunol; 1998 Apr; 10(4):517-26. PubMed ID: 9620608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
    Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
    J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner.
    Rodríguez-Pinto D; Moreno J
    Eur J Immunol; 2005 Apr; 35(4):1097-105. PubMed ID: 15756646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
    Johnson-Léger C; Christenson JR; Holman M; Klaus GG
    J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
    Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
    J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new multivalent B cell activation model--anti-IgD bound to Fc gamma RI: properties and comparison with CD40L-mediated activation.
    Cho S; Conrad DH
    Int Immunol; 1997 Feb; 9(2):239-48. PubMed ID: 9040006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.